10 research outputs found
Rak dojke u mladih žena: patoloŔka i imunohistokemijska obilježja
A young woman with breast cancer is considered to be a woman younger than 40. According to the literature, breast cancer in the population of young women usually is of a higher histologic grade, unfavorable hormonal status, and overall higher mortality rate when compared with breast cancer occurring in older population. We compared pathologic and immunohistochemical features of breast carcinoma in women under 40 years of age with the respective features in women over 60 years of age. The following parameters were observed in these two groups: tumor size, lymph node status, histologic grade, hormonal receptor status, Ki-67 prognostic index, Her2/neu status, and histologic type of the tumor. Early onset breast carcinoma was found to have a higher frequency of tumor grade 3 (29% vs. 17%) and estrogen receptor negativity (45% vs. 23%). In the group of young women, breast carcinoma was mostly multicentric (23% vs. 5%), triple-negative (32% vs. 10%), and was found to have higher proliferation index Ki-67 (25% vs. 10%). Our results confirmed differences between the young and older groups of patients. In the group of young women, we found predominantly unfavorable prognostic parameters of the disease.Mladom ženom s rakom dojke smatra se žena mlaÄa od 40 godina. Prema literaturi rak dojke u populaciji mladih žena ima obiÄno viÅ”i histoloÅ”ki stupanj i nepovoljan hormonski status. Puno je veÄi postotak smrtnosti u mladoj populaciji nego kada se karcinom javlja u starijoj životnoj dobi. Usporedili smo patoloÅ”ka i imunohistokemijska obilježja karcinoma dojke kod žena ispod 40 godina s odgovarajuÄim obilježjima meÄu ženama iznad 60 godina. SljedeÄi parametri su promatrani kod ove dvije skupine: veliÄina tumora, stanje limfnih Ävorova, histoloÅ”ki gradus, status hormonskih receptora, prognostiÄki indeks Ki-67, status Her2/neu i histoloÅ”ki tip tumora. Za karcinom dojke kod mladih žena utvrÄeno je da ima veÄu uÄestalost tumora histoloÅ”kog gradusa 3 (29% prema 17%) i negativnog statusa estrogenskih receptora (45% prema 23%). U skupini mladih žena rak dojke je uglavnom multicentriÄan (23% prema 5%), trostruko negativan (32% prema 10%) i ustanovljeno je da ima veÄi proliferacijski indeks Ki-67 (25% prema 10%). NaÅ”i rezultati potvrÄuju razlike izmeÄu mlade i starije skupine bolesnica. U skupini mladih žena utvrÄeni su pretežito nepovoljni prognostiÄki parametri bolesti
Biomechanical Analysis of the Gracilis and Superficial Third of the Quadriceps Tendons Concerning MPFL Biomechanics
The primary goal of this research is the analysis of the biomechanical performances of most common transplants (distal tendon of m.gracilis and upper third of m.quadriceps femoris) used for the reconstruction of the medial patellofemoral ligament (MPFL). The secondary goal is the comparison of the data obtained from the research with the data available in the literature.The research was conducted on 16 samples of the human tendon, of which there are 8 gracilis tendons and 8 quadriceps tendons. Tensile strength is significantly higher in gracilis tendon (26 MPa - 92 MPa) than in quadriceps tendon (30 MPa - 44 MPa). The extensibility is significantly higher in the quadriceps tendon (10% - 15%) than in the gracilis tendon (13% - 17%). Regarding stiffness (N/mm) there are no significant differences between the groups of gracilis and quadriceps tendons. The module of elasticity is significantly higher in gracilis tendon (235 MPa - 855 MPa) in comparison to quadriceps tendon (239 MPa - 361 MPa).The biomechanical characteristics of the distal surface third of the quadriceps tendon are more favourable than the distal tendon of the gracilis which could prove applicable in operative techniques of reconstruction of the medial patellofemoral ligament when choosing a transplant
Neovisni Äimbenici za loÅ”u prognozu kod mladih bolesnica s rakom dojke I.-III. stadija
Breast cancer is the most common malignancy in the population of women under 40 years of age. Young age is an independent factor for poor prognosis. In this research, we tried to establish other factors for poor prognosis in stage I-III breast cancer. The following parameters were observed: tumor size, lymph node status, histologic grade, hormonal receptor status, Ki-67 prognostic index, Her2 neu status, histologic type of the tumor, local recurrence and metastases. Logistic regression was used to evaluate the effect of specific factors on the probability of lethal outcome and development of distant metastases. Our patients showed a predominance of T1 tumor (49.4%), had positive
lymph nodes (62%) and most of them were pN1 (61.2%). Up to one-third of patients had triple negative status. Ki-67 proliferation index was high (25%). Multicentric tumor was detected in 23% of patients. There was no difference in overall survival between the two types of surgical procedures. Patients with pN0 status had better overall survival. Breast cancer in the population of young women has a more aggressive nature. Study results indicated positive lymph node status as an independent factor for poor prognosis of stage I-III breast cancer.Rak dojke je najÄeÅ”Äi zloÄudni tumor u populaciji žena u dobi ispod 40 godina. Mlada dob je neovisan Äimbenik za loÅ”u prognozu. Željeli smo utvrditi i druge Äimbenike loÅ”e prognoze kod raka dojke I.-III. stadija kod mlade populacije žena. Uzeli smo u obzir sljedeÄe parametre: veliÄinu tumora, stanje limfnih Ävorova, histoloÅ”ki stupanj, status hormonskih receptora, Ki-67 prognostiÄki indeks, HER 2 neu status, histoloÅ”ki tip tumora, lokalni recidiv i razvoj udaljenih metastaza. LogistiÄka regresija koriÅ”tena je za procjenu utjecaja Äimbenika na vjerojatnost smrtnog ishoda i razvoja udaljenih metastaza. NaÅ”e bolesnice imale su veÄinom tumor T1 (49,4%), pozitivne limfne Ävorove (62%), a veÄina njih bile su pN1 (61,2%). Do jedne treÄine bolesnica imale su trostruko negativan hormonski status. Ki-67 indeks proliferacije bio je visokih 25%. NaÅ”li smo uÄestalost multicentriÄnog tumora kod 23% bolesnice. Nije bilo razlike u preživljenju izmeÄu dviju vrsta kirurÅ”kog zahvata. Bolesnice sa statusom limfnih Ävorova pN0 imale su bolje preživljenje. Rak dojke kod mlade populacije žena ima agresivniju prirodu. Rezultati istraživanja ukazali su na pozitivan status limfnih Ävorova kao nezavisan Äimbenik za loÅ”u prognozu raka dojke I.-III. stadija
KirurÅ”ko lijeÄenje prijeloma potkoljenice
Podaci prikazani u radu dobiveni su retrospektivnom analizom medicinske dokumentacije Odjela za traumatologiju Klinike za kirurgiju KBC-a Osijek, u razdoblju od 1.1.2010. do 31.12.2010. Rad obuhvaÄa 130 pacijenata (72 muÅ”ka i 58 ženskih) u dobi od 4 do 83 godine. Rezultati istraživanja ukazuju da su prijelomi potkoljenice zastupljeni sa 130 od 658 prijeloma dugih kostiju (20%). NajÄeÅ”Äi tip prijeloma je prijelom donje treÄine potkoljenice (43,08%). NajÄeÅ”Äa metoda lijeÄenja je operacijska sa 125 zahvata u odnosu na 5 pacijenata lijeÄenih konzervativno. Prema metodi osteosinteze najÄeÅ”Äe su upotrebljavani vijci i ploÄice
Razina leptina u serumu kod raka dojke
Leptin is a polypeptide which is mostly produced in white fat tissue and is an
important proinflammatory, proangiogenic, proinvasive and mitotic factor. There is ever more evidence
suggesting the key role of leptin in the occurrence of breast cancer. The aim of the study was
to investigate serum leptin levels in patients with benign breast tumors, as well as in various breast
cancer phenotypes, taking into account leptin levels connected to menopausal status and body mass
index (BMI). The study included 97 patients having their breast tumor surgically removed. Serum
leptin level was determined by ELISA method in all study patients. Study results showed that significantly
more women, regardless of having malignant or benign tumors, were postmenopausal and
had a significantly higher level of leptin compared to the premenopausal group. The highest level of
leptin was recorded in the group of postmenopausal obese women compared to other postmenopausal
women but also compared to premenopausal women. According to BMI alone, obese women had a
significantly higher level of leptin regardless of the type of tumor. The most significant differences in
leptin levels observed through BMI were found in the Luminal B1 group. In conclusion, serum leptin
level was shown to be a good diagnostic parameter suggesting a higher possibility of breast cancer
development.Leptin je polipeptid koji se uglavnom proizvodi u bijelom masnom tkivu te predstavlja važan proupalni, proangiogeni,
proinvazivni i mitotiÄki Äimbenik. Sve je viÅ”e dokaza koji ukazuju na kljuÄnu ulogu leptina u nastanku tumora dojke.
Istraživali smo serumsku razinu leptina u bolesnica s benignim tumorima dojke, kao i kod razliÄitih fenotipova malignih
tumora dojke te ovisnost razine leptina o reproduktivnom statusu i indeksu tjelesne mase (ITM). Istraživanje je obuhvatilo
97 bolesnica kojima je tumor uklonjen kirurÅ”kim zahvatom. Serumska koncentracija leptina utvrÄena je metodom ELISA u
svih bolesnica ukljuÄenih u istraživanje. Znatno viÅ”e žena, bez obzira na to jesu li imale zloÄudni ili dobroÄudni tumor, bilo je
u postmenopauzi te su imale znaÄajno viÅ”e razine leptina u usporedbi s premenopauzalnim skupinama. NajviÅ”a razina leptina
utvrÄena je kod pretilih žena u postmenopauzi u usporedbi s drugim ženama u postmenopauzi, ali i u usporedbi sa ženama
u premenopauzi. Prema ITM, pretile ispitanice su imale znaÄajno viÅ”e razine leptina bez obzira na vrstu tumora. NajznaÄajnije
razlike u razinama leptina, promatrane kroz ITM, utvrÄene se u skupini Luminal B1. Razina leptina u serumu je dobar
dijagnostiÄki parametar koji govori u prilog veÄoj predispoziciji za nastanak karcinoma dojke
Prijelomi distalnog okrajka nadlaktiÄne kosti kod djece
Rezultati istraživanja dobiveni na temelju podataka iz medicinske dokumentacije Odjela djeÄje kirurgije KBC-a Osijek uglavnom se ne razlikuju od podataka iz literature. Od ukupno 43 pacijenta sa suprakondilarnim prijelomom humerusa, starosti do 15 godina, 24 pacijenta bila su muÅ”kog spola, a 19 pacijenata bilo je ženskog spola. Prijelomi su najÄeÅ”Äi u dobi od 6 do 11 godina (25 pacijenata). NajÄeÅ”Äe su nastali tijekom pada u igri, s bicikla, kreveta i sl. Dominantna strana za nastanak prijeloma bila je lijeva (26 pacijenata). U lijeÄenju suprakondilarnih prijeloma dominira repozicija uz imobilizaciju (30 pacijenata), potom repozicija s vanjskom fiksacijom (10 pacijenata), a otvorena repozicija i unutarnja fiksacija primijenjene su tek kod 3 pacijenta
Prijelomi distalnog okrajka nadlaktiÄne kosti kod djece
Rezultati istraživanja dobiveni na temelju podataka iz medicinske dokumentacije Odjela djeÄje kirurgije KBC-a Osijek uglavnom se ne razlikuju od podataka iz literature. Od ukupno 43 pacijenta sa suprakondilarnim prijelomom humerusa, starosti do 15 godina, 24 pacijenta bila su muÅ”kog spola, a 19 pacijenata bilo je ženskog spola. Prijelomi su najÄeÅ”Äi u dobi od 6 do 11 godina (25 pacijenata). NajÄeÅ”Äe su nastali tijekom pada u igri, s bicikla, kreveta i sl. Dominantna strana za nastanak prijeloma bila je lijeva (26 pacijenata). U lijeÄenju suprakondilarnih prijeloma dominira repozicija uz imobilizaciju (30 pacijenata), potom repozicija s vanjskom fiksacijom (10 pacijenata), a otvorena repozicija i unutarnja fiksacija primijenjene su tek kod 3 pacijenta
Izražaj TFF gena i proteina u tumorima dojke
The objective of this study was to determine diff erential expression of TFF1, TFF2 and TFF3 genes and proteins in breast tumor subtypes. In addition, we investigated the correlation between TFF genes within tumor subgroups, and TFF genes with clinical and pathologic characteristics of the tumor. Study group included 122 patients with surgically removed breast tumors. Samples were investigated using qRT-PCR and immunohistochemistry. TFF1 and TFF3 genes and proteins were expressed in breast tumors, while the levels of TFF2 gene and protein expression were very low or undetectable. TFF1 was signifi cantly more expressed in benign tumors, while TFF3 was more expressed in malignant tumors. Gene and protein expression of both TFF1 and TFF3 was greater in lymph node-negative tumors, hormone positive tumors, tumors with moderate levels of Ki67 expression, and in grade II tumors. A strong positive correlation was found between TFF1 and TFF3 genes, and the expression of both negatively correlated with Ki67 and the level of tumor histologic diff erentiation. Our results suggest that TFF1 and TFF3, but not TFF2, may have a role in breast tumor pathogenesis and could be used in the assessment of tumor diff erentiation and malignancy.Cilj ovoga istraživanja bio je utvrditi razlike u izražaju gena i proteina TFF1, TFF2 i TFF3 u razliÄitim vrstama tumora dojke te ispitati korelacije izmeÄu gena TFF i vrsta tumora te gena TFF i kliniÄko-patoloÅ”kih karakteristika tumora. U studiju su bile ukljuÄene 122 ispitanice kojima je kirurÅ”ki odstranjen tumor dojke. Uzorci su obraÄeni metodom qRT-PCR i metodom imunohistokemije. Geni i proteini TFF1 i TFF3 bili su izraženi u tumorima dojke, dok izražaj gena i proteina TFF2 nije otkriven u tumorskom tkivu. TFF1 je bio izraženiji kod dobroÄudnih tumora, dok je TFF3 bio izraženiji kod zloÄudnih tumora. TFF1 i TFF3 su bili izraženiji u hormonski ovisnim tumorima, tumorima bez metastaza u limfnim Ävorovima, tumorima s umjereno visokim izražajem Ki67 i umjereno diferenciranim tumorima. Jaka pozitivna korelacija uoÄena je izmeÄu gena TFF1 i TFF3, a oba su negativno korelirala s faktorom Ki67 i stupnjem diferenciranosti tumora. Dobiveni rezultati pokazuju kako bi TFF1 i TFF3 mogli imati ulogu u patogenezi tumora dojke te bi se potencijalno mogli rabiti za odreÄivanje tumorskog statusa i procjenu malignosti tumora
Breast Cancer in Young Women: Pathologic and Immunohistochemical Features
A young woman with breast cancer is considered to be a woman younger than 40. According to the literature, breast cancer in the population of young women usually is of a higher histologic grade, unfavorable hormonal status, and overall higher mortality rate when compared with breast cancer occurring in older population. We compared pathologic and immunohistochemical features of breast carcinoma in women under 40 years of age with the respective features in women over 60 years of age. The following parameters were observed in these two groups: tumor size, lymph node status, histologic grade, hormonal receptor status, Ki-67 prognostic index, Her2/neu status, and histologic type of the tumor. Early onset breast carcinoma was found to have a higher frequency of tumor grade 3 (29% vs. 17%) and estrogen receptor negativity (45% vs. 23%). In the group of young women, breast carcinoma was mostly multicentric (23% vs. 5%), triple-negative (32% vs. 10%), and was found to have higher proliferation index Ki-67 (25% vs. 10%). Our results confirmed differences between the young and older groups of patients. In the group of young women, we found predominantly unfavorable prognostic parameters of the disease
Differential Expression of TFF Genes and Proteins in Breast Tumors
The objective of this study was to determine diff erential expression of TFF1, TFF2 and TFF3 genes and proteins in breast tumor subtypes. In addition, we investigated the correlation between TFF genes within tumor subgroups, and TFF genes with clinical and pathologic characteristics of the tumor. Study group included 122 patients with surgically removed breast tumors. Samples were investigated using qRT-PCR and immunohistochemistry. TFF1 and TFF3 genes and proteins were expressed in breast tumors, while the levels of TFF2 gene and protein expression were very low or undetectable. TFF1 was signifi cantly more expressed in benign tumors, while TFF3 was more expressed in malignant tumors. Gene and protein expression of both TFF1 and TFF3 was greater in lymph node-negative tumors, hormone positive tumors, tumors with moderate levels of Ki67 expression, and in grade II tumors. A strong positive correlation was found between TFF1 and TFF3 genes, and the expression of both negatively correlated with Ki67 and the level of tumor histologic diff erentiation. Our results suggest that TFF1 and TFF3, but not TFF2, may have a role in breast tumor pathogenesis and could be used in the assessment of tumor diff erentiation and malignancy